Midwest Microlab Competitors

Jordi Labs, an RQM+ company, delivers regulator-credible testing, toxicology, and scientific consulting that de-risk submissions and get safe MedTech products to patients faster. We are widely recognized for chemical and material characterization and extractables and leachables (E&L) testing. Our solutions include E&L studies, toxicological risk assessments, biological evaluations, polymer deformulation, unknown identification, and contaminant and failure investigations. Our PhD analytical chemists use a proprietary multi-detector approach frequently cited by regulators and industry to generate precise, decision-ready data. As part of RQM+, the MedTech CRO, we combine world-class laboratory science with end-to-end regulatory, quality, clinical, and reimbursement expertise, so MedTech teams move from development through post-market with fewer surprises and greater confidence.

Drug Discovery Research Service provider company working out of southwestern Suburbs of Chicago (USA) www.chicagodiscoverysolutions.com. It is the mission of Chicago Discovery Solutions LLC (CDS) to find innovative solutions which will facilitate discovery of innovative drugs and truly applicable green technologies. Our core strength in innovative Chemistry, ability to conceive new pharmacophores, lead generation and optimization of lead molecules for ADME and/or toxicity can help companies involved in drug discovery research. Our scientists have an outstanding track record of achievements in heterocyclic and medicinal chemistry.They have the demonstrated success in starting programs by generating pharmacophores and taking the molecules all the way to clinical trial stages. Chicago Discovery Solutions (CDS) facilitates and accelerates Medicinal Chemistry research by making available special building blocks as privileged structures. Our building blocks are carefully selected and assembled in a constantly updated catalogue. Most of these small 'non-planar' structures provide 3 D exit vectors for substitutions which are very useful for medicinal chemists. We are involved in the development of new and more efficient heterogeeous catalysts for C-C coupling (in-house R&D program).

AsisChem is the only US company that leverages expert chemistry teams in St. Petersburg, Russia to support drug discovery projects worldwide. Since 2005 companies looking to advance drug discovery projects have entrusted AsisChem's scientists with their hit-to-lead and lead optimization efforts. AsisChem's medicinal chemistry team members have dozens of years of drug discovery experience and act as medicinal chemistry program leaders for AsisChem's customers. AsisChem's synthetic team of 30 PhD chemists has three core groups: medicinal chemistry support, process optimization and research. More than 100 different organizations have used AsisChem's services since its inception. 55% of AsisChem's current customers are pharmaceutical and biotechnology companies, four of which are publicly traded. AsisChem is also a preferred partner for dozens of universities and non-profit institutes.